Pharmacovigilance is a dynamic clinical and scientific discipline and; its scope extends beyond the detection of new signals of safety concerns.  Pharmacovigilance contributes to the assessment of benefits, effectiveness and risks of medicines, encouraging their safe, rational and more effective use.
Since FPi upper management recognizes the eminent role of Pharmacovigilance, that’s why, there’s a dedicated email account medical_inforamtion@future-eg.com for receiving any case reports or even queries from the public. FPi was the first national company to include this email address in all the insert leaflets of its products, in order to facilitate timely safety reporting and direct communication. 
The ultimate goal of such pharmacovigilance activities is to serve public health and improve patient care in relation to the use of medicines, which will lead to fostering a sense of trust among the public in the medicines they use. Pharmacovigilance aims at protecting patients from unnecessary harm by identifying previously unrecognized drug hazards and quantifying risk in relation to benefit.
The major functions of Pharmacovigilance include: 

  •  The early detection & documentation of drug-related problems and; the enhancement of understanding of the mechanisms which are responsible for such problems.
  • The anticipation and management of any risks associated with the drug use through proper identification and quantification of the risk factors and taking the necessary actions to prevent them or minimize their negative impact
  •  The communication of the drugs’ updated benefit/risk profiles to health care professionals, patients and regulatory authorities.